Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited12.4679581076106.4299
Domestic EquitiesApollo Hospitals Enterprise Limited7.29888493662.3048
Domestic EquitiesCipla Limited6.764637709857.7450
Domestic EquitiesLupin Limited4.786119621440.8557
Domestic EquitiesAbbott India Limited4.55651293338.8960
Domestic EquitiesTorrent Pharmaceuticals Limited4.465210244638.1161
Domestic EquitiesJ.B. Chemicals & Pharmaceuticals Limited4.305320748436.7516
Domestic EquitiesAurobindo Pharma Limited4.185429125435.7281
Domestic EquitiesFortis Healthcare Limited4.065237756434.7019
Domestic EquitiesAjanta Pharmaceuticals Limited3.879212931233.1142
Domestic EquitiesIPCA Laboratories Limited3.748322019731.9968
Domestic EquitiesEmcure Pharmaceuticals Ltd2.945117775725.1402
Domestic EquitiesMankind Pharma Ltd2.652110057422.6392
Domestic EquitiesAlkem Laboratories Limited2.33353503919.9197
Domestic EquitiesJupiter Life Line Hospitals Ltd2.278513140819.4497
Domestic EquitiesThyrocare Technologies Limited2.059035457917.5765
Domestic EquitiesDivi's Laboratories Limited1.97282600016.8402
Domestic EquitiesALEMBIC PHARMACEUTICALS LIMITED1.969218529416.8099
Domestic EquitiesSAI Life Sciences Ltd1.916518498816.3603
Domestic EquitiesShilpa Medicare Ltd1.708142696414.5808
Domestic EquitiesMETROPOLIS HEALTHCARE LIMITED1.51926716012.9686
Domestic EquitiesDr. Reddys Laboratories Limited1.45959897512.4590
Domestic EquitiesMedi Assist Healthcare Services Ltd1.455126152712.4212
Domestic EquitiesProcter & Gamble Health Limited1.27371900010.8728
Domestic EquitiesBiocon Limited1.267527161510.8198
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.23404099710.5342
Domestic EquitiesJubilant Pharmova Ltd1.21139488610.3397
Domestic EquitiesSuraksha Diagnostic Ltd1.14783347369.7977
Domestic EquitiesSANOFI CONSUMER HEALTHCARE1.0455191538.9247
Domestic EquitiesGland Pharma Limited1.0307500008.7980
Domestic EquitiesPiramal Pharma Ltd0.96504400008.2372
Domestic EquitiesPfizer Limited0.9616165008.2088
Domestic EquitiesMax Healthcare Institute Limited0.9535700008.1396
Domestic EquitiesVijaya Diagnostic Centre Limited0.9144782107.8057
Domestic EquitiesVinati Organics Limited0.8739472227.4597
Total 97.6699 833.7433
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Limited1.6775 14.3200
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.6525 5.5702
Total 2.3301 19.8902
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.